UK to fast-track Covid-19 vaccine approval if sought before end of Brexit transition

UK health officials suggested that, should a vaccine’s developers be ready to seek approval before the end of the year, the MHRA might be able to give a faster verdict than its European counterpart. The health department said: “If a vaccine is discovered before 2021, the proposals will bolster existing powers that allow the MHRA to consider approving its use, before a full product licence is granted, provided it is proven to be safe and effective during robust and extensive clinical trials.” The measures were necessary because during the transition period, a new potential Covid-19 vaccine must be granted a licence by the EMA, it said.